Therapy for advanced lung cancer (NSCLC) is continually changing thus the updated algorithm included in this post.
Diabetics Suffer From Vitamin D and B12 Deficiency and Tumor Acceleration
Lung Cancer (NSCLC) Updated Algorithm November 2016
Reasonable Expectations from Radiation Therapy for Prostate Cancer: Got Cure Yet?
Choosing Watchful Waiting as a Prostate Cancer Strategy: What to Consider
Current as well as several studies in the past have addressed the value of the Watchful Waiting strategy as a "treatment" modality for localized low-risk and favorable intermediate risk prostate cancer. This blog helps determine whether the Watchful Waiting modality may be compatible with your clinical situation.
NEW DRUG/HOPE FOR ADVANCED PROSTATE CANCER PATIENTS
You need to know about this if you have advanced, castrate resistant (hormone refractory) prostate cancer!
Glenn Tisman, M.D.
BREAST CANCER, SUGAR, INSULIN: INCREASED SURVIVAL WITH METFORMIN?
Newer studies reveal that survival of breast cancer is strongly associated with results of a readily available blood test , the blood insulin level. We now know, based on several clinical studies, that insulin supports tumor cell growth not only in the test tube but also in the patient. The commonly used anti-diabetic drug Metformin (Glucophage) appears to be a way to fight back by lowering blood insulin levels.
THE NEW REVISED MULTIPLE MYELOMA STAGING SYSTEM (R-ISS) INCREASES ACCURACY OF PREDICTING SURVIVAL
You can now have a better understanding of the potential impact on life of the diagnosis of Multiple Myeloma. Many patients that carry the diagnosis will require no more than watchful waiting while others, once thought to have indolent disease, may actually require immediate therapy for best results. You and your physician can discuss the implications of the newer and Revised-International Staging System for Multiple Myeloma (R-ISS).
Glenn Tisman, M.D.
BEWARE OF THE BREAST CANCER SURVIVAL FLIP FLOP....WHAT YOU CAN DO ABOUT IT
The newly recognized delayed breast cancer recurrence several years after therapy (10-25 years) is just coming to the forefront of discussion among medical oncologists. Here I demonstrate the problem and discuss some solutions you can discuss with your own physicians.
Charts modified from: JCO March 20, 2016 vol. 34 no. 9 927-935
I HAVE BREAST CANCER…HOW LONG CAN I EXPECT TO SURVIVE?
Simple review of a surgical pathology report reveals important information that will help the patient evaluate the answer to "How Long Can I Expect To Survive?" However remember we are all individuals and not numbers and every few months a new medication with breakthrough efficacy has become available offering cure for many.
Glenn Tisman, M.D.